Different stimulation conditions affect the immune phenotype of GD2-specific chimeric antigen receptor-expressing T cells

被引：0
|
作者：
Ochs, Laurin
Altvater, Bianca
Kailayangiri, Sareetha
Spurny, Christian
Rossig, Claudia
Jamitzky, Silke
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2314
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2314
引用
收藏
页数：3
相关论文
共 50 条
  • [41] NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma
    Xu, Xin
    Huang, Wei
    Heczey, Andras
    Liu, Daofeng
    Guo, Linjie
    Wood, Michael
    Jin, Jingling
    Courtney, Amy N.
    Liu, Bin
    Di Pierro, Erica J.
    Hicks, John
    Barragan, Gabriel A.
    Ngai, Ho
    Chen, Yuhui
    Savoldo, Barbara
    Dotti, Gianpietro
    Metelitsa, Leonid S.
    CLINICAL CANCER RESEARCH, 2019, 25 (23) : 7126 - 7138
  • [42] Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy
    Murad, Joana M.
    Baumeister, Susanne H.
    Werner, Lillian
    Daley, Heather
    Trebeden-Negre, Helene
    Reder, Jake
    Sentman, Charles L.
    Gilham, David
    Lehmann, Frederic
    Snykers, Sarah
    Sentman, Marie-Louise
    Wade, Terri
    Schmucker, Adam
    Fanger, Michael W.
    Dranoff, Glenn
    Ritz, Jerome
    Nikiforow, Sarah
    CYTOTHERAPY, 2018, 20 (07) : 952 - 963
  • [43] Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
    A Barber
    K R Meehan
    C L Sentman
    Gene Therapy, 2011, 18 : 509 - 516
  • [44] The specific cytotoxicities of chimeric antigen receptor-engineered T cells on different lymphomas
    张蕊
    ChinaMedicalAbstracts(InternalMedicine), 2017, 34 (04) : 230 - 230
  • [45] Anti-tumor efficacy of chimeric NKG2D receptor-expressing T cells requires the induction of host immune responses
    Barber, Amorette
    Rynda, Agnieszka
    Zhang, Tong
    Sentman, Charles
    CANCER RESEARCH, 2009, 69
  • [46] Highly efficient gene transfer using a retroviral vector into murine T cells for preclinical chimeric antigen receptor-expressing T cell therapy
    Kusabuka, Hotaka
    Fujiwara, Kento
    Tokunaga, Yusuke
    Hirobe, Sachiko
    Nakagawa, Shinsaku
    Okada, Naoki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 473 (01) : 73 - 79
  • [47] Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
    Barber, A.
    Meehan, K. R.
    Sentman, C. L.
    GENE THERAPY, 2011, 18 (05) : 509 - 516
  • [48] Genetically engineered T cells expressing a HER2-specific chimeric receptor mediate antigen-specific tumor regression
    S Li
    J Yang
    F A Urban
    J N MacGregor
    D P M Hughes
    A E Chang
    K T Mcdonagh
    Q Li
    Cancer Gene Therapy, 2008, 15 : 382 - 392
  • [49] Genetically engineered T cells expressing a HER2-specific chimeric receptor mediate antigen-specific tumor regression
    Li, S.
    Yang, J.
    Urban, F. A.
    MacGregor, J. N.
    Hughes, D. P. M.
    Chang, A. E.
    Mcdonagh, K. T.
    Li, Q.
    CANCER GENE THERAPY, 2008, 15 (06) : 382 - 392
  • [50] Recent Advances in the Use of Chimeric Antigen Receptor-Expressing T-Cell Therapies for Treatment of Multiple Myeloma
    Martin, Thomas
    Jackson, Carolyn C.
    Pacaud, Lida
    Madduri, Deepu
    Jagannath, Sundar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01): : 22 - 27
12345